Arch Pharmalabs Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Arch Pharmalabs Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013093
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arch Pharmalabs Ltd (Arch Pharmalabs) is a healthcare products company that offers pharmaceutical ingredients. The company manufactures, develops and markets active APIs and intermediates to innovator and generic pharmaceutical players. It offers products such as docetaxel anhydrous and trihydrate, amlodipine besylate, perindopril erbumine, trandolapril, timolol maleate, etofylline nicotinate, and montelukast sodium products, among others. Arch Pharmalabs also provides salmeterol xinafoate, terbutaline sulphate, amodiaquine hydrochloride, benztropine mesylate, gemcitabine hydrochloride, irinotecan hydrochloride, paclitaxel hydrochloride, metoclopramide hydrochloride, pantoprazole and sodium sesquihydrate, among others. The company offers services such as contract research and manufacturing services. Its therapeutic areas include anti hypertensive, anti anginal, anti emetic, expectorant, decongestants, proton pump inhibitors and analgesic, among others. Arch Pharmalabs is headquartered in Mumbai, Maharashtra, India.

Arch Pharmalabs Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Intrexon and Arch Pharmalabs Enter into Agreement 10
Equity Offering 11
Arch Pharmalabs Files For IPO Of US$29.7 Million 11
Asset Transactions 12
Neuland Lab to Acquire Manufacturing Facility from Arch Pharmalabs 12
Acquisition 13
Mitsui Completes Acquisition Of Additional 27.29% Stake In Arch Pharmalabs For US$69 Million 13
Arch Pharmalabs Ltd – Key Competitors 15
Arch Pharmalabs Ltd – Key Employees 16
Arch Pharmalabs Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Arch Pharmalabs Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Arch Pharmalabs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Intrexon and Arch Pharmalabs Enter into Agreement 10
Arch Pharmalabs Files For IPO Of US$29.7 Million 11
Neuland Lab to Acquire Manufacturing Facility from Arch Pharmalabs 12
Mitsui Completes Acquisition Of Additional 27.29% Stake In Arch Pharmalabs For US$69 Million 13
Arch Pharmalabs Ltd, Key Competitors 15
Arch Pharmalabs Ltd, Key Employees 16

★海外企業調査レポート[Arch Pharmalabs Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heidelberger Druckmaschinen AG (HDD):企業の財務・戦略的SWOT分析
    Heidelberger Druckmaschinen AG (HDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Umeme Limited (UMEME):電力:M&Aディール及び事業提携情報
    Summary Umeme Limited (Umeme) is an electricity distribution utility. The company operates, maintains, upgrades, and expands the electricity distribution system in the country. It sources power from Uganda Electricity Transmission Company Limited which purchases energy from all independent power pro …
  • Centre for Drug Design and Discovery:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution operates as an investment fund and technology transfer platform to promote the discovery and development of medicines for all kinds of diseases. It provide …
  • SonaCare Medical LLC-医療機器分野:企業M&A・提携分析
    Summary SonaCare Medical LLC (SonaCare Medical), formerly US HIFU LLC is a medical device company that manufactures minimally invasive high intensity focused ultrasound (HIFU) surgical ablation systems for urological indications. The company's products include sonablate 450 and sonatherm. It offers …
  • Bank J.Van Breda & C° NV:企業の戦略・SWOT・財務情報
    Bank J.Van Breda & C° NV - Strategy, SWOT and Corporate Finance Report Summary Bank J.Van Breda & C° NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MITIE Group Plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Park Electrochemical Corp (PKE):企業の財務・戦略的SWOT分析
    Summary Park Electrochemical Corp (Park Electrochemical) is a technology company that develops and manufactures high technology digital and radio frequency and microwave printed circuit materials. The company provides advanced composite materials in product forms such as broadgoods, unidirectional t …
  • Hologic Inc (HOLX):企業の財務・戦略的SWOT分析
    Hologic Inc (HOLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Syncardia Systems LLC:医療機器:M&Aディール及び事業提携情報
    Summary Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients sufferin …
  • Origin Energy Limited:企業の戦略・SWOT・財務情報
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sterling Bank Plc:企業の戦略・SWOT・財務分析
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bloomsbury Publishing Plc (BMY):企業の財務・戦略的SWOT分析
    Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Affibody AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Affibody AB (Affibody) is a biotech company that discovers and develops next generation biopharmaceuticals and related drugs. The company discovers and develops drugs based on its proprietary technology platforms such as Albumod and Affibody molecules. Its Affibody molecules are a class of a …
  • Steris Plc (STE):製薬・医療:M&Aディール及び事業提携情報
    Summary Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and ba …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務分析
    Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Metso Corp (METSO):電力:M&Aディール及び事業提携情報
    Summary Metso Corp (Metso) is an industrial machinery company that provides sustainable technology and services. It offers products such as mining and construction aggregates processing equipments, conveyers, separators, air classifiers, slurry pumps, industrial valves and controls, and waste shredd …
  • Shin-Etsu Chemical Co Ltd (4063):企業の財務・戦略的SWOT分析
    Shin-Etsu Chemical Co Ltd (4063) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Forrester Research Inc (FORR):企業の財務・戦略的SWOT分析
    Summary Forrester Research Inc (Forrester) is a market research company that offers research and advisory services. The company offers services such as custom consulting, proprietary research, consumer and business data, worldwide events and peer executive programs. Forrester provides research for p …
  • UnitedHealth Group Incorporated:企業の戦略・SWOT・財務分析
    UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report Summary UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Neuwave Medical Inc-医療機器分野:企業M&A・提携分析
    Summary NeuWave Medical Inc (NeuWave), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. Its flagship product, Certus 140 microwave ablation (coagulation) system, is a minimally invasive soft tissue ablation s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆